Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
Abstract B-cell-maturation-antigen (BCMA)-directed therapies are highly active for multiple myeloma, but infections are emerging as a major challenge. In this retrospective, single-center analysis we evaluated infectious complications after BCMA-targeted chimeric-antigen-receptor T-cell therapy (CAR...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group
2024-05-01
|
| Reeks: | Blood Cancer Journal |
| Online toegang: | https://doi.org/10.1038/s41408-024-01043-5 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
